Genetically Engineered Vaccines for Dental Caries
Genetically Engineered Vaccines for Dental Caries
© Copyright 2025 1. Dentistry, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Navi Mumbai, IND 2.
Mulla et al. This is an open access article Orthodontics and Dentofacial Orthopaedics, Bharati Vidyapeeth (Deemed to be University) Dental College and
distributed under the terms of the Creative Hospital, Navi Mumbai, IND 3. Pedodontics and Preventive Dentistry, Bharati Vidyapeeth (Deemed to be University)
Commons Attribution License CC-BY 4.0., Dental College and Hospital, Navi Mumbai, IND 4. Conservative Dentistry and Endodontics, Bharati Vidyapeeth
which permits unrestricted use, distribution,
(Deemed to be University) Dental College and Hospital, Navi Mumbai, IND
and reproduction in any medium, provided
the original author and source are credited.
Corresponding author: Sayem A. Mulla, sayemmullaa@[Link]
DOI: 10.7759/cureus.88491
Abstract
Despite conventional preventive measures including dental sealants, dietary changes, and fluoride
treatments, dental caries (DC) is still a global health issue. An important pathogen in DC development,
Streptococcus mutans, forms biofilms and demineralizes enamel in acidic oral conditions. Promising
substitutes are provided by new preventative techniques such as genetic engineering, probiotics, and
antibacterial peptides. A potential long-term remedy is the genetically altered BCS3-L1 strain, which is
intended to outcompete S. mutans and stop the generation of acid. Even though these developments have
the potential to completely transform oral healthcare, further study is required to guarantee their efficacy,
safety, and public acceptability. The aim of this review is to highlight the salient features, the probable
mechanism behind it, while also exploring the limitations associated with it and shedding light on the future
prospects of the strain.
Lack of access to dental treatment increases the burden of DC in many underprivileged and disadvantaged
populations, resulting in a circle of untreated oral health problems that can cause pain, infection, and a
decline in general well-being. Higher rates of untreated decay and related consequences arise from people's
inability to seek prompt preventative treatment due to financial limitations, a lack of awareness, and an
inadequate healthcare infrastructure. Inequalities in oral health education also led to a lack of knowledge
about the significance of early intervention, appropriate hygiene habits, and dietary choices [4]. The surge of
DC cases worldwide in spite of preventative measures indicates that creative, affordable solutions catered to
the particular requirements of these susceptible groups must be added to standard techniques.
In order to enhance oral health outcomes, emerging caries prevention strategies emphasize the use of
innovative technology, community-based therapies, and microbiome-targeted techniques. New
developments in probiotics, antimicrobial peptides, and customized preventive treatment present viable
substitutes for lowering the burden of cariogenic bacteria and strengthening the body's defences against
dental decay. Community-driven oral health initiatives, tele dentistry, and mobile dental clinics can all
assist close the access gap and make sure that people who need preventative treatment can get it [5].
Furthermore, including oral health education into public health campaigns and school curriculum can
promote enduring behaviours that support long-term caries prevention. These cutting-edge strategies have
the potential to lessen the worldwide burden of DC and advance universal oral health by targeting the
biological and socioeconomic factors of DC [6].
Review
Methodology
A literature search was carried out on multiple scholarly databases such as PubMed, ScienceDirect, Web of
Science and Google Scholar to identify scholarly articles. The keywords used included "genetically
engineered vaccines", "dental caries", and "genetically modified vaccines" in various combinations of
Boolean operators. Only studies available in the English language were selected, and no restriction on
publication year was applied. The initial search results were then screened by authors SAM, WZK and LNM
for their relevance for inclusion in this narrative article. After careful assessment, a total of 28 articles were
included in this narrative synthesis.
Carbohydrate metabolism Converts sugars into lactic acid, leading to enamel erosion
Apart from being acidogenic, S. mutans is also aciduric, which means that it can live and grow in acidic
environments that would be harmful to other oral bacteria. It has a competitive edge thanks to this
capability, which enables it to control the microbial population in plaque. In addition, S. mutans has
virulence factors such as bacteriocins, which prevent the development of competing bacteria, and
glucosyltransferases, which help produce sticky glucans that promote bacterial colonization. High levels of
S. mutans are closely linked to a higher risk of DC, particularly in cases where frequent use of carbohydrates
and poor oral hygiene are present. In order to prevent plaque buildup and neutralize acid production,
preventive methods including consistent brushing, flossing, fluoride treatment, and dietary changes are
essential [8-10]. Specifically, fluoride reduces the cariogenic potential of S. mutans by inhibiting bacterial
metabolism and aiding in the remineralization of enamel. Knowing how this bacterium contributes to the
pathophysiology of DC emphasizes how crucial it is to preserve oral health in order to stop tooth decay from
getting worse [11].
Dental sealants Creates a protective barrier Expensive and needs professional application
Genetic engineering Modifies Streptococcus mutans to reduce cariogenicity Requires further research and regulatory approval
In light of these difficulties, there is an increasing need to investigate long-term, alternative preventative
strategies that do not only depend on patient compliance. By more sustainably addressing the underlying
causes of oral disorders, innovations like biomimetic materials, probiotics, and new antimicrobial peptides
provide encouraging remedies. For instance, without needing patient effort, bioactive compounds that
release calcium and phosphate ions can help with enamel repair [14]. In a similar vein, probiotics that add
good bacteria to the oral microbiome can aid in the suppression of dangerous pathogens, lowering the risk of
gum disease and cavities. Furthermore, methods based on gene therapy and nanotechnology are being
researched for their capacity to alter bacterial behavior and strengthen defences. The future of preventive
dentistry may provide more egalitarian and successful techniques for preserving oral health by reorienting
the focus from conventional, behaviour-dependent approaches to sophisticated, self-sustaining solutions
[15].
Live attenuated strains Reduces acidogenicity while retaining colonization ability BCS3-L1 strain
Recombinant antigen-based vaccines Uses specific S. mutans antigens to elicit an immune response GTFs, PAc, Antigen I/II
In addition to vaccinations, probiotic treatments that outcompete S. mutans or counteract its negative
effects have also been developed through genetic engineering. To prevent S. mutans from adhering to tooth
surfaces and forming cariogenic biofilms, researchers have altered beneficial bacterial strains, such as
Lactobacillus species, to create antimicrobial peptides or enzymes that specifically target S. mutans.
Introducing genetically altered S. mutans strains that are unable to produce lactic acid is another novel
strategy that lessens acid-induced enamel demineralization [20]. In place of conventional fluoride
treatments and mechanical plaque removal, these designed probiotic therapies offer a sustainable and
perhaps self-replicating method of preventing DC. Such treatments have enormous potential to
revolutionize oral healthcare and lessen the prevalence of DC worldwide, provided that genetic engineering
continues to improve [21].
The generation of mutacin-1140, a strong lantibiotic that selectively targets and inhibits unmodified S.
mutans strains, is a crucial characteristic of BCS3-L1. BCS3-L1 has a competitive advantage because of its
selective antibacterial function, which enables it to dominate oral biofilms without endangering beneficial
oral bacteria. Mutacin-1140 offers a more focused approach than broad-spectrum antibiotics, which have the
potential to upset the equilibrium of the oral microbiota and cause secondary infections [24,25]. In order to
preserve a healthy oral environment and stop dangerous S. mutans strains from recolonizing, this specificity
is essential. BCS3-L1 is a novel tool for managing oral health since it employs such a tailored antibacterial
approach [22].
Beyond preventing cavities, BCS3-L1 may have further advantages. This strain may lessen problems
associated with oral acidity, such as dentin erosion and hypersensitivity, by decreasing the amount of acid
produced in dental biofilms. Furthermore, BCS3-L1 colonization in the oral cavity over time may lessen the
need for regular dental procedures, which would save money for both private citizens and public health
systems [11]. To guarantee its safety, efficacy, and long-term stability in a variety of populations,
comprehensive clinical trials and regulatory authorization are required prior to broad use. If BCS3-L1 is
effective, it might completely transform dental treatment by offering a biological, sustainable way to stop
tooth decay at its source (Table 4).
An innovative method of avoiding DC brought on by S. mutans is provided by the BCS3-L1 strain, which is a
breakthrough in dental microbiology. To inhibit S. mutans and lower the risk of tooth decay, traditional
techniques like fluoride treatments and antimicrobial rinses must be used consistently. These therapies do
not, however, permanently change the makeup of the oral microbiome, making patients susceptible to
recurring infections. BCS3-L1 is a genetically altered bacterial strain that, on the other hand, is intended to
outcompete S. mutans and create a stable, non-cariogenic microbial habitat [26]. After a single application,
BCS3-L1 offers a lifetime preventive effect by colonizing the oral cavity and displacing harmful bacteria,
obviating the need for recurring treatments.
A single injection can result in the steady replacement of S. mutans with a harmless bacterial population,
according to research on BCS3-L1 in animal models. By occupying the same ecological niche as S. mutans,
BCS3-L1 prevents its recolonization through a process known as competitive exclusion [22]. BCS3-L1 creates
a persistent presence in the oral microbiome, providing long-term protection against DC, in contrast to
traditional probiotics that need to be taken on a regular basis [24]. Furthermore, research shows that the
strain improves oral health by supporting a balanced microbial environment rather than impairing total
microbial diversity. This strategy fits in with the increasing interest in microbiome-based treatments, which
try to use good bacteria to prevent illness [16].
Beyond affecting a person's oral health, BCS3-L1 may lessen the prevalence of DC, one of the most common
infectious illnesses in the world. BCS3-L1 may considerably reduce the need for restorative dental
treatments and the medical expenses related to cavity treatment by offering a one-time, permanent solution
[27]. In addition, its use in public health campaigns may increase access to preventive care in
underprivileged areas where fluoride treatments and routine dental checkups may be scarce. However,
further clinical research is required to verify its long-term safety, effectiveness, and regulatory approval
prior to broad use. By changing the focus from ongoing preventative care to a single, long-lasting
intervention, BCS3-L1 has the potential to completely transform dental care if it is properly adopted [2].
Oral dysbiosis Disrupting the natural microbiome may lead to other infections
Combination therapies Integrate with existing preventive methods for enhanced efficacy
Synthetic biology innovations Develop bacteria with enhanced biofilm disruption properties
TABLE 6: Future studies that can improve the literature for genetically modified vaccines.
Conclusions
A revolutionary method of preventing dental cavities is represented by genetically modified vaccinations
and bacterial strains. An innovative illustration of the potential for modified S. mutans to offer long-term
cavity prevention is the BCS3-L1 strain. However, before these technologies can be extensively used, safety
issues, moral dilemmas, and legal barriers need to be resolved. Genetically modified vaccinations have the
potential to transform oral healthcare and drastically lower the prevalence of DC worldwide with more study
and advancements in technology.
Additional Information
Author Contributions
All authors have reviewed the final version to be published and agreed to be accountable for all aspects of the
work.
Concept and design: Sayem A. Mulla, Waseem Z. Khan, Amit H. Patil, Parag Gangurde, Tanvi Shukla
Acquisition, analysis, or interpretation of data: Sayem A. Mulla, Waseem Z. Khan, Laresh N. Mistry
Critical review of the manuscript for important intellectual content: Sayem A. Mulla, Waseem Z. Khan,
Laresh N. Mistry, Parag Gangurde, Tanvi Shukla
Disclosures
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the
following: Payment/services info: All authors have declared that no financial support was received from
any organization for the submitted work. Financial relationships: All authors have declared that they have
no financial relationships at present or within the previous three years with any organizations that might
have an interest in the submitted work. Other relationships: All authors have declared that there are no
other relationships or activities that could appear to have influenced the submitted work.
References
1. Veiga N, Figueiredo R, Correia P, Lopes P, Couto P, Fernandes GV: Methods of primary clinical prevention of
dental caries in the adult patient: an integrative review. Healthcare (Basel). 2023,
11:10.3390/healthcare11111635
2. Moore D, Allen T, Birch S, Tickle M, Walsh T, Pretty IA: How effective and cost-effective is water
fluoridation for adults? Protocol for a 10-year retrospective cohort study. BDJ Open. 2021, 7:3.
10.1038/s41405-021-00062-9
3. Patrick DL, Lee RS, Nucci M, Grembowski D, Jolles CZ, Milgrom P: Reducing oral health disparities: a focus
on social and cultural determinants. BMC Oral Health. 2006, 6 Suppl 1:S4. 10.1186/1472-6831-6-S1-S4
4. MacDougall H: Dental disparities among low-income American adults: a social work perspective . Health Soc
Work. 2016, 41:208-10. 10.1093/hsw/hlw026
5. Yu X, Devine DA, Vernon JJ: Manipulating the diseased oral microbiome: the power of probiotics and
prebiotics. J Oral Microbiol. 2024, 16:2307416. 10.1080/20002297.2024.2307416
6. Das H, Janakiram C, Ramanarayanan V, et al.: Effectiveness of an oral health curriculum in reducing dental
caries increment and improving oral hygiene behaviour among schoolchildren of Ernakulam district in
Kerala, India: study protocol for a cluster randomised trial. BMJ Open. 2023, 13:e069877. 10.1136/bmjopen-
2022-069877
7. Sivapathasundharam B, Rajendran R: Shafer’s textbook of oral pathology. 5th edition. Elsevier Health
Sciences, 2005. [Link]
hl=en&lr=&id=Spk0V6TrCggC&oi=fnd&pg=PR3&dq=info:0SRQWZ_wUvQJ:[Link]&ots=....
8. Lemos JA, Palmer SR, Zeng L, et al.: The biology of Streptococcus mutans . Microbiol Spectr. 2019,
7:10.1128/microbiolspec.GPP3-0051-2018
9. Koo H, Xiao J, Klein MI, Jeon JG: Exopolysaccharides produced by Streptococcus mutans
glucosyltransferases modulate the establishment of microcolonies within multispecies biofilms. J Bacteriol.
2010, 192:3024-32. 10.1128/JB.01649-09
10. Georgios A, Vassiliki T, Sotirios K: Acidogenicity and acidurance of dental plaque and saliva sediment from
adults in relation to caries activity and chlorhexidine exposure. J Oral Microbiol. 2015, 7:26197.
10.3402/jom.v7.26197
11. Ravuru N, Reginald BA, Reddy BS, Samatha M: Relationship between dental fluorosis, dental caries and
salivary levels of Streptococcus mutans. J Oral Maxillofac Pathol. 2023, 27:603. 10.4103/jomfp.jomfp_59_23
12. Sicca C, Bobbio E, Quartuccio N, Nicolò G, Cistaro A: Prevention of dental caries: a review of effective
treatments. J Clin Exp Dent. 2016, 8:e604-10. 10.4317/jced.52890
13. Baryakova TH, Pogostin BH, Langer R, McHugh KJ: Overcoming barriers to patient adherence: the case for
developing innovative drug delivery systems. Nat Rev Drug Discov. 2023, 22:387-409. 10.1038/s41573-023-
00670-0
14. Tao J, Sun Y, Wang G, Sun J, Dong S, Ding J: Advanced biomaterials for targeting mature biofilms in
periodontitis therapy. Bioact Mater. 2025, 48:474-92. 10.1016/[Link].2025.02.026
15. Shirbhate U, Bajaj P, Chandak M, Jaiswal P, Sarangi S, Suchak D, Bharti L: Clinical implications of probiotics
in oral and periodontal health: a comprehensive review. Cureus. 2023, 15:e51177. 10.7759/cureus.51177
16. Hillman JD: Genetically modified Streptococcus mutans for the prevention of dental caries . Antonie Van
Leeuwenhoek. 2002, 82:361-6.
17. Huang Y, Hajishengallis G, Michalek SM: Induction of protective immunity against Streptococcus mutans
colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium
expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter. Infect Immun. 2001,
69:2154-61. 10.1128/IAI.69.4.2154-2161.2001
18. de Souza Pereira G, Batista MT, Dos Santos NF, et al.: Streptococcus mutans glutamate binding protein
(GlnH) as antigen target for a mucosal anti-caries vaccine. Braz J Microbiol. 2022, 53:1941-9.
10.1007/s42770-022-00823-0
19. Smith DJ: Dental caries vaccines: prospects and concerns . Crit Rev Oral Biol Med. 2002, 13:335-49.
10.1177/154411130201300404
20. Luo SC, Wei SM, Luo XT, Yang QQ, Wong KH, Cheung PC, Zhang BB: How probiotics, prebiotics, synbiotics,
and postbiotics prevent dental caries: an oral microbiota perspective. NPJ Biofilms Microbiomes. 2024,
10:14. 10.1038/s41522-024-00488-7
21. Zhang J, Wang Q, Duan Z: Preventive effects of probiotics on dental caries in vitro and in vivo . BMC Oral
Health. 2024, 24:915. 10.1186/s12903-024-04703-x
22. Hillman JD, Brooks TA, Michalek SM, Harmon CC, Snoep JL, van Der Weijden CC: Construction and
characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries.
Infect Immun. 2000, 68:543-9. 10.1128/IAI.68.2.543-549.2000
23. Pradeep P, Thomas AR, Kaur K, Sarah Samson R, Mayya A, Adiga S, Kumbargere Nagraj S: Herbal medicines
to prevent dental caries. Cochrane Database Syst Rev. 2024, 5:CD015832. 10.1002/14651858.CD015832
24. Smith L, Zachariah C, Thirumoorthy R, Rocca J, Novák J, Hillman JD, Edison AS: Structure and dynamics of
the lantibiotic mutacin 1140. Biochemistry. 2003, 42:10372-84. 10.1021/bi034490u
25. Kers JA, Sharp RE, Defusco AW, et al.: Mutacin 1140 lantibiotic variants are efficacious against Clostridium
difficile infection. Front Microbiol. 2018, 9:415. 10.3389/fmicb.2018.00415
26. Frey J: Biological safety concepts of genetically modified live bacterial vaccines . Vaccine. 2007, 25:5598-605.
10.1016/[Link].2006.11.058
27. Giacaman RA, Fernández CE, Muñoz-Sandoval C, et al.: Understanding dental caries as a non-communicable
and behavioral disease: management implications. Front Oral Health. 2022, 3:764479.
10.3389/froh.2022.764479
28. Bohua L, Yuexin W, Yakun O, Kunlan Z, Huan L, Ruipeng L: Ethical framework on risk governance of
synthetic biology. J Biosaf Biosecu. 2023, 5:45-56. 10.1016/[Link].2023.03.002